Quince Therapeutics, Inc. (QNCX)
Latest QNCX Insider Trades
- Luca BenattiOpen-market sale$174K
David LamondGrant or award2,700 sh- Christopher J. SennerGrant or award2,700 sh
About Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
- SOUTH SAN FRANCISCO, CA
- 38
- 2019
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 16,703,562 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
QNCX Insider Transactions (Form 4)
2012 Form 4 filings on record, the earliest from Jun 4, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Lamond | Grant or award | Director Stock Option (Right to Buy) | 2,700 |
Recent QNCX Form 8-K Filings
5QNCX Insider Trading - FAQ
What is the latest insider trade for QNCX?
Quince Therapeutics, Inc. (QNCX) had 3 insider filings in the last 90 days, with the most recent on 2026-06-15. The full record for QNCX runs to 12 Form 4 filings, the earliest from 2025-06-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying QNCX stock?
No insider purchases of QNCX were filed in the last 90 days.
How many insiders are selling QNCX stock?
No insider sales of QNCX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see QNCX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks QNCX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow QNCX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add QNCX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - David Lamond view on EDGAR
- - Christopher J. Senner view on EDGAR
- - Brigette Roberts view on EDGAR
- - Dirk Thye view on EDGAR
- - Charles S. Ryan view on EDGAR
- - Brendan Hannah view on EDGAR
- - Christopher J. Senner view on EDGAR
- - Margaret McLoughlin view on EDGAR
- - David Lamond view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where QNCX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track QNCX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
